Macrophages, unlike most other cells, possess both low density lipoprotein (LDL) and scavenger receptors. The scavenger receptor has been shown to mediate the uptake of oxidized LDL (ox-LDL), which ultimately leads to cholesterol loading of the macrophages. The present study was undertaken to define epitopes on ox-LDL that are important for lipoprotein binding to macrophages and to ascertain whether ox-LDL can bind to the LDL receptor. Monoclonal antibodies (Mabs) directed against several epitopes along the apolipoprotein B-100 (apo B-100) molecule were used. LDL (300 /tg/ml) was oxidized by incubation with 10 jtM CuSO, for 24 hours. Ox-LDL, as opposed to acetylated LDL (ac-LDL), reacted with Mabs directed against the LDL receptor-binding domains (Mabs B1B6 and B1B3). Similarly, uptake of ox-LDL but not ac-LDL by a murine J774 macrophage-like cell line was inhibited by as much as 40% after using Mab B1B6. The anti-LDL receptor antibody IgG-C7 also inhibited '"I-ox-LDL uptake by macrophages by 60%. Chromatography on heparin-Sepharose columns of LDL that was partially oxidized for only 3 hours resulted in two fractions: an unbound traction with characteristics similar to those of ox-LDL and a bound fraction similar to native LDL. Macrophage degradation of the unbound fraction was inhibited by Mab IgG-C7 and Mab B1B6, whkh are directed toward the LDL receptor and the LDL receptor-binding domains on apo B-100, respectively. When incubated with three types of macrophages, J774 macrophage cells, mouse peritoneal macrophages, and human monocyte-derived macrophages, excess amounts of unlabeled ox-LDL, like native LDL but unlike ac-LDL, substantially suppressed the uptake and degradation of l25 l-labekd LDL. Similar studies with fibroblasts, however, revealed that unlabeled LDL but not unlabeled ox-LDL or ac-LDL competed with ""I-LDL for cellular uptake and degradation. Mab directed against epitopes on the amino terminus domain of apo B-100 (C14) demonstrates a similar immunoreactivity with ox-LDL and native LDL but a much lower reactivity with ac-LDL. Mab C14 inhibited macrophage degradation of ox-LDL by 34% but had no inhibitory effect on the uptake of native LDL or ac-LDL. Thus, the ac-LDL and LDL receptor-binding domains as well as a unique epitope on the ammo terminus of apo B-100 may be involved in macrophage binding of ox-LDL. We conclude that 1) ox-LDL contains epitopes that are also present in native LDL, although considerable changes in these epitopes are suggested and 2) these epitopes are involved in the uptake of ox-LDL by macrophages. {Arteriosclerosis and Thrombosis 1992;12:484-493) KEY WORDS • oxidized low density lipoproteins • monoclonal antibodies • macrophages M acrophages, like those resident in the atherosclerotic lesion, poorly take up native low density lipoprotein (LDL), whereas several modified forms of LDL are taken up avidly by the macrophage scavenger receptor.
M acrophages, like those resident in the atherosclerotic lesion, poorly take up native low density lipoprotein (LDL), whereas several modified forms of LDL are taken up avidly by the macrophage scavenger receptor. 18 and dialyzed against saline-EDTA (0.9% [wt/vol] NaCl, 1 mM EDTA). LDL was diluted in phosphate-buffered saline (PBS) to 300 fig protein/ml and dialyzed overnight against PBS at 4°C. LDL was then oxidized by incubation in the presence of 10 jiM CuSO 4 at 37°C for 24 hours (unless stated differently). Oxidation was terminated by refrigeration and addition of 0.1 mM EDTA. The degree of oxidation was determined by malondialdehyde (MDA) analysis using the thiobarbituric acid reactivesubstances (TBARS) assay. 19 Lipoprotein conjugated dienes were measured at 234 nm. 20 The presence of reactive amino groups was determined with trinitrobenzenesulfonic acid (TNBS) by mixing LDL (50 fig protein) with 1 ml 4% NaHCO 3 , pH 8.4, and adding 50 fi\ 0.1% TNBS. After incubation for 1 hour at 37°C, 100 fi\ of IN H Q and 100 fi\ of 10% sodium dodecyl sulfate (SDS) were added, and the absorbance at 340 nm was measured. TNBS reactivity was expressed as a percentage of the absorbance obtained for nonoxidized LDL.
The protein content of lipoproteins was determined with the Folin phenol reagent by the method of Lowry et al. 21 Cholesterol was analyzed by the ferric chloride assay. 22 Ac-LDL, which was employed as the control in some experiments, was prepared by acetylating LDL with acetic anhydride as described by Goldstein et al. 23 LDL was radioiodinated using the iodine monochloride method, 24 and the specific radioactivity of 125 I-LDL was 160-235 cpm/ng. The iodinated LDL was found to be similar to native LDL in its electrophoretic characteristics, TNBS reactivity, and heparin binding.
125 I-ox-LDL was prepared by iodination performed before the modification. This procedure did not interfere with the modification, as analyzed by the electrophoretic mobility pattern.
The electrophoretic characteristics of the lipoproteins were determined on cellulose acetate as previously described. 25 Gradient (3-12%) SDS-polyacrylamide gel electrophoresis (SDS-PAGE) of the lipoproteins was performed under reducing conditions using ^-mercaptoethanol. 26 Protein bands were identified by Coomassie blue staining. To determine the relative diameters of lipoproteins, electrophoresis was also performed in nondenaturing gradient polyacrylamide gels (3-10%) as described by Krauss and Burke. 27 
Heparin-Sepharose Chromatography
To determine the degree of possible contamination of ox-LDL by native LDL, both LDL and ox-LDL were submitted to heparin-Sepharose affinity chromatography. 28 Sepharose complexed with heparin (Affi-gel Heparin, Bio-Rad, Richmond, Calif.) was packed into a small column (1.5x8 cm). The column was equilibrated with 0.05 M NaCl and 2 mM phosphate buffer (pH 7.4) containing 0.01% (vol/vol) NaN 3 . One milligram of lipoprotein protein was applied to the column, and elution was begun at a flow rate of 30 ml/hr. After the unbound fraction was eluted (and the absorbance at 280 nm had decreased to baseline), the retained fraction (bound) was eluted with 0.8 M NaCl. Recovery of the lipoprotein protein ranged between 80% and 85%. The capacity of the column for LDL binding was more than double the loads used.
Immunoreactivity of Lipoproteins
The epitope expression on apo B-100 associated with native LDL, ox-LDL (oxidized for 24 hours at 37°C by incubation with 10 /xM CuSO 4 ), and ac-LDL was determined using a solid-phase competitive-binding radioimmunoassay. 29 LDL, ox-LDL, and ac-LDL were assayed in competitive displacement assays on microtiter plates. The plates were coated with 150 /xl of purified Mabs (10 /ig/ml) and left overnight, and then the wells were blocked with 3% bovine serum albumin (BSA)-PBS. Serial dilutions of ox-LDL or ac-LDL in 1% (vol/vol) BSA-PBS were added followed by a constant amount of 125 I-LDL (500 ng). After incubation for 4 hours at room temperature, the wells were washed three times with PBS, and binding (B) was determined using a gamma counter. The maximum binding (Bo) was obtained in wells to which no competing antigen lipoprotein had been added. The results were expressed as the B to Bo ratio.
Production of Monoclonal Antibodies
Female BALB/c mice were immunized with human LDL between densities 1.025-1.050 g/ml or purified apo E. Initial injections of antigen were made with Freund's complete adjuvant followed at 3-4-week intervals by injections with Freund's incomplete adjuvant. Antibody titers of mouse sera were tested 5-10 days after the last subcutaneous injection. Splenic cell fusions were performed using SP2/0-Agl4 mouse myeloma cells. Hybridoma culture supernatants were screened for immunoreactivity with their respective immunogens by either solid-phase antigen or direct-binding assays. Positive clones were subcloned, retested for activity, and expanded as ascites tumors in Pristane (2,6,10,14-tetramethylpentadecane; Sigma Chemical Co., St. Louis, Mo.)-treated BALB/c mice. Monoclonal immunoglobulin G (IgG) antibodies were purified by ion-exchange chromatography on an FPLC Mono Q column (BioRad).
Anti-human Mabs against apo B-100 and apo E epitopes were produced in mice using intact very low density lipoprotein (VLDL) or LDL and apo E as immunogens as previously described. 30 - 31 The epitopes for these Mabs had been mapped to the apo B regions of amino acid residues from the amino to the carboxyl terminus: 97-401 (C14), 401-582 (D3D5), 1,878-2,148 (D72), 3,214-3,506 (B1B6), and 3,506-3,635 (B1B3). Immunoreactivity of ox-LDL in comparison with native LDL and ac-LDL was studied.
Cells
The effects of Mabs on the uptake of radiolabeled ox-LDL and LDL by cells were determined. Three different sources of macrophages, the J774A macrophage-like cell line, mouse peritoneal macrophages (MPMs), and human monocyte-derived macrophages (HMDMs), were employed. Similar experiments were performed using human skin fibroblasts. The cells were prepared as follows.
J774A.1 macrophage like-cell line. Murine macrophage-like J774A.1 cells were grown and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (vol/vol) fetal calf serum, penicillin (100 units/ml), and streptomycin (100 /ig/ml). For each experiment the cells were plated in 16x35-mm dishes at lipoproteins (300 /ig protein/ml) were incubated with copper ions for the time intervals presented in the table. The conjugated dienes, thiobarbiruric acid-reactive substances (TBARS), trinitrobenzenesulfonic acid (TNBS), and total cholesterol (TC) to protein ratios were measured as described in "Methods." Results are given as meaji±SD (n=3).
MDA, malondialdehyde.
a density of 10 6 cells/dish and incubated at 37°C in an atmosphere containing 5% CO 2 /95% air.
Mouse macrophage monolayers. MPMs were harvested in PBS containing 0.5 units heparin/ml 4 days after intraperitoneal injection of 4% (vol/vol) Brewer thiogfycollate. 31 Peritoneal fluid from 10 mice (10-20x10* cells/mouse) was pooled, and the cells were collected by centrifugation at l,000g for 10 minutes at room temperature. The cells were resuspended in DMEM containing 15% (vol/vol) horse serum (heat inactivated at 56°C for 30 minutes), penicillin (100 units/ml), and streptomycin (100 mg/ml) to a final concentration of 1& cells/ml. The cell suspension was dispensed into 16-mm wells in plastic dishes (10 6 cells/ well) and incubated in a humidified incubator (5% CO 2 / 95% air at 37°C) for 2 hours. Then each dish was washed once with 2-3 ml DMEM to remove nonadherent cells and incubated under similar conditions for 18 hours. The experiment was initiated by changing the medium to DMEM containing 0.2% (vol/vol) BSA without (control) or with the various lipoproteins. Each 10 6 adherent cells contained 70-100 /xg protein.
Human monocyte-derived macrophages. Mononuclear cells were isolated by density gradient centrifugation of blood derived from fasting normolipidimic subjects. 32 Twenty milliliters of blood (anticoagulated with 10 units/ml heparin) was layered over 15 ml Ficoll-Paque in Leucosep tubes (Pharmacia Fine Chemicals, Piscataway, NJ.) and centrifuged at l.OOOg for 15 minutes at 23°C. The mixed mononuclear cell band was removed by aspiration, and the cells were washed twice with PBS. Cells were resuspended in RPMI-1640 culture medium containing 100 units/ml penicillin and 100 ^.g/ml streptomycin and plated at a density of 5X10 5 monocytes/ 16-mm well (Primaria brand, Falcon Labware, Becton Dickinson & Co., Oxnard, Calif.) in the same medium containing 10% (vol/vol) autologous serum. After 18 hours of incubation at 37°C in 5% CO 2 , nonadherent cells were removed by two washes with serum-free medium, and monocytes were then placed in fresh medium containing 10% (vol/vol) autologous serum. This medium was changed after 5 days, and monocytederived macrophages were used after 10 days of plating.
Human skin fibroblasts were used after six passages. The cells were plated at 2X10 4 cells/16-mm dish in DMEM containing 10% (vol/vol) lipoprotein-deficient serum for 48 hours before the beginning of the experiment
Cellular Uptake of Lipoproteins
Cellular uptake and degradation of the 125 I-ox-LDL (obtained after 24 hours of oxidation, unless stated differently) were determined after 5 hours of cell incubation at 37°C with the labeled lipoproteins, with or without Mabs, by measuring the trichloroacetic acidsoluble noniodide radioactivity in the medium. 33 At the end of the incubations the cells were washed with PBS (three times) and dissolved in 0.1 M NaOH, and aliquots were taken for determination of cell protein and cell-associated radioactivity. In experiments in which Mabs were tested for their ability to inhibit lipoprotein uptake by macrophages, purified Mabs were added to 125 I-lipoprotein preparations. These mixtures were incubated for 1 hour before being applied to the cells for cellular lipoprotein degradation analysis. MPMs and HMDMs were also used after upregulation of their LDL receptors by a 24-hour preincubation with 10% (vol/vol) lipoprotein-deficient serum.
Results

Physicochemical Characterization of Oxidized Low Density Lipoprotein
The effect of increasing the time of incubation with copper ions on LDL is shown in Table 1 . Conjugated dienes and TBARS increased as the oxidation time increased, while TNBS reactivity decreased, with the maximal effect achieved after 4 hours. The composition of ox-LDL changed as time progressed, and after 24 hours the oxidized particle contained 40% less cholesterol relative to protein. These changes were accompanied by a gradual increase in electrophoretic mobility on cellulose acetate (Figure 1 ). Even though LDL migrated as a broad homogeneous particle at all time intervals, it may contain at certain time points before completion of its oxidation both modified and nonmodified fractions, as LDL oxidation continued for as long as 6 hours before reaching a maximal level of TBARS. SDS-PAGE of the ox-LDL showed fragmentation of the apo B-100 until its almost-complete disappearance after 24 hours of incubation with copper ions (but not after 6 hours, even though MDA levels were maximal after 6 hours of oxidation). The size of the oxidized particles, however, was not changed, as determined by nondenaturing gradient gel electrophoresis (data not shown). Heparin binds to the LDL surface by interacting with the positively charged amino acid residues of apo B-100. On heparin-Sepharose chromatography of ox-LDL, the relative content of the unbound fraction increased and that of the bound lipoprotein decreased as the duration of oxidation was prolonged ( Table 2 ). In a control experiment, ac-LDL failed to bind to heparin (data not shown). The unbound fraction obtained after chromatography of LDL that was oxidized for only 3 hours resembled nonchromatographed LDL that was oxidized for 24 hours, as shown by increased concentration of LDL conjugated dienes (by 50%), decreased TNBS reactivity (by 31%), and a reduced cholesterol to protein ratio (from 1.50 to 1.01) in comparison with the bound fraction. On lipoprotein electrophoresis, the bound and unbound fractions migrated as homogeneous fractions to 1.5±0.2 cm and 2.8±0.3 cm from the origin, respectively, similar to native and ox-LDL, which migrated to 1.4±0.2 cm and 2.3±0.4 cm from the origin, respectively. Fragmentation of the apo B-100 of ox-LDL was also a feature of the unbound fraction, whereas the bound fraction showed no evidence of apo B-100 fragmentation (data not shown).
Immunoreactivity of Oxidized Low Density Lipoprotein
The immunoreactivity of LDL, ox-LDL, and ac-LDL was studied using several Mabs directed against different epitopes along the apo B-100 molecule (Figure 2 ). Solid-phase immunoassays showed that the immunoreactivity of ox-LDL (in comparison with native LDL) with Mabs B1B3 and B1B6 (located on the carboxyl terminus of apo B-100 and related to the LDL receptor) Low density lipoprotein (LDL) and oxidized LDL were applied to a heparin-Sepharose column (1.5x8 cm). The unbound fraction was eluted with 0.05 M NaCl, while the retained fraction was eluted with 0.8 M Nad as described in "Methods." To determine the percentage of bound and unbound lipoprotein, a pooledfraction protein determination was performed, and the percentage of unbound was calculated as [unbound/(bound+unbound)] x 100. Recovery of the lipoprotein protein from the column averaged 83% of the protein loaded. Results are given as mean±SD (n=3).
decreased by 55% (Table 3) . Very little reactivity of ox-LDL with Mab D72, located in the middle of the apo B-100 molecule (Figure 2) , and with Mab D3D5, located toward the amino terminus domain of apo B-100, was noted (Table 3 ). The immunoreactivity curves illustrating competition toward Mab C14 (located on the amino terminal domain of apo B-100) with both LDL and ox-LDL were similar (Figure 2 ). LDL diluted in PBS and incubated for 24 hours in the absence of copper ions demonstrated the same immunoreactivity as native LDL (data not shown). Ac-LDL demonstrated very low immunoreactivity with Mabs B1B6, B1B3, and C14 (50% effective dose [EDJO] of 30.3, 28.1, and 35 /ig/ml, respectively) and also reacted very poorly with Mab D72 (Table 3 ). However, with Mab D3D5 almost the same ED^ was obtained with ac-LDL as with native LDL (Table 3 ). These results show that ox-LDL interacted with at least three different Mabs, which reacted with epitopes located on the amino terminus and the carboxyl terminus domains of native apo B-100.
Effect of Monoclonal Antibodies on Lipoprotein Uptake by Macrophages
The ability of the Mabs to block cellular uptake of ox-LDL was studied in experiments performed on a J774 macrophage cell line. Similar to the immunoreactivity results shown in Figure 2 , Mabs B1B6 and C14 (20 jig/ml) inhibited ox-LDL degradation by 40% and 30%, respectively, while Mab D72 had no effect (Figure 3) . Cellular association of ox-LDL was similarly affected by all Mabs (Figure 3 ). The inhibitory effect was dose dependent, with a maximal effect shown at a Mab concentration of 50 figlwl (Figure 4 ). Macrophage degradation rates of ac-LDL and native LDL were not affected by Mab C14 (20 /ig/ml), whereas Mab B1B6 did not affect the degradation of ac-LDL but did reduce cellular degradation of LDL by 66% (data not shown). An anti-apo E Mab (WU-E-7) directed against the receptor-binding domain of apo E did not affect the metabolism of ox-LDL. Similar studies were also performed in the presence and absence of the anti-LDL receptor Mab, IgG-C7. LDL and ox-LDL degradations were inhibited by 80% and 60%, respectively, whereas the degradation of ac-LDL was not affected by IgG-C7. To eliminate native LDL from the ox-LDL preparation, •^I-ox-LDL that was partially oxidized (by LDL incubation with copper ions for only 3 hours) was applied onto a heparin-Sepharose column, and the radioiodinated, unbound, oxidized fraction ( I23 I-ub-ox-LDL) was tested for its uptake by macrophages in the absence and presence of Mabs B1B6, C14, and IgG-C7. As shown in Figure 5 , all these Mabs (at a concentration of 50 /xg/ml) inhibited the degradation of 125 I-ub-ox-LDL by J774 macrophages by 70-80%. These results demonstrate that epitopes present on ox-LDL, which are shared by those present on native LDL, were involved in the uptake of ox-LDL by macrophages.
Competitive Analysis of Cellular Uptake of Oxidized Low Density Lipoprotein
To further clarify the interaction of ox-LDL with the macrophage LDL receptor, experiments were performed using HMDMs, MPMs, and J774 macrophages as well as human skin fibroblasts. Both cell association 
FIGURE 2. Semilog plots of competitive radioimmunoassay studies of native low density lipoprotein (LDL) and oxidized LDL (ox-LDL) after 24 hours of oxidation with four different monoclonal antibodies for apoUpoprotein B-100 epitopes. Microtiter wells were coated with monoclonal antibodies (10 fjg/ml) and left overnight. After blocking with 3% bovine serum albumin-phosphatebuffered saline (BSA-PBS), serial dilutions of LDL (•) or ox-LDL (o)inl% (volfvol) BSA-PBS were added, followed by addition of 500 ng m I-LDL. After incubation for 4 hours, wells were washed and counted in a gamma counter. Results are expressed as the ratio between individual counts (B) and the counts obtained in the absence of competitor (B o ).
and degradation of 125 I-LDL and 12s I-ox-LDL were studied. Increasing concentrations of unlabeled LDL, ox-LDL, and ac-LDL were tested for their ability to inhibit cellular uptake of the 123 I-labeled lipoproteins. The results show that in J774 macrophages but not in fibroblasts, unlabeled ox-LDL significantly competed Microtiter wells were coated with the monoclonal antibodies (Mabs), and varying amounts of unlabeled native or modified low density lipoprotein (LDL) were added to each well followed by the addition of ^I-LDL (500 ng, 1,000 cpm/well). Results (mean±SD, 7i=3) are expressed as the 50% effective dose (ED50) in micrograms per milliliter (the amount of unlabeled lipoprotein required to reduce the radioactivity to 50% compared with the radioactivity without a competitor).
Ox, oxidized; Ac, acetylated. When ^I-ox-LDL was used, competition experiments ( Figures 6C and 6D ) demonstrated that unlabeled LDL inhibited 125 I-ox-LDL degradation by as much as 30% in comparison with 75% and 46% inhibition by unlabeled ox-LDL and ac-LDL, respectively ( Figure 6C ). In fibroblasts, however, uptake of 125 I-ox-LDL could not be found ( Figure 6D ). Similar results were obtained for the cellular association of 125 I-labeled lipoproteins in all competition studies performed either at 37°C or at 4°C (data not shown).
To determine whether the ability of ox-LDL to compete with LDL for uptake by murine J774 macrophages (but not by fibroblasts) was unique for the J774 macrophages or applied to macrophages in general, we performed similar competition experiments using MPMs and HMDMs (Figure 7) *I-LDL degradation by 70%, whereas unlabeled ac-LDL had no effect on Figures 7C and 7D) . The addition of a 50-fold excess of unlabeled LDL, together with the excess ox-LDL, further inhibited macrophage degradation of ^I-ox-LDL by 82% and 85% in MPMs and HMDMs, respectively (data not shown). Unlabeled ac-LDL, while demonstrating greater competition than unlabeled LDL (as much as a 30% reduction in ^I-ox-LDL degradation), still competed less than unlabeled ox-LDL ( Figures 7C and 7D) . Similar results were found for cellular associations of the labeled lipoproteins (data not shown).
Discussion
Ox-LDL was previously shown to bind to the ac-LDL receptor. 9 The present study indicates that the interaction of ox-LDL with macrophages resides in at least three domains identified by specific Mabs, which react with recognized epitopes on apo B-100. As shown by the immunoassays and by Mab inhibition of ox-LDL uptake by macrophages, these epitopes on ox-LDL apo B-100 include domains on the amino terminus of the apolipoprotein and also toward the carboxyl terminus domain. The latter epitopes correspond to the classical LDL receptor-binding domains. These domains are specific for ox-LDL, as ac-LDL, another modified form of lipoprotein that is a ligand for the macrophage scavenger receptor, shows no interaction with these Mabs, which also fail in turn to inhibit macrophage uptake of ac-LDL. Thus, despite LDL oxidation the recognized LDL receptor-binding domain is retained by ox-LDL, and an additional domain on the amino terminus appears to unravel. The binding of ox-LDL to the cells may be dependent on the presence of both receptors, acting in concert, for the uptake of ox-LDL. It is also possible that the epitopes on the carboxyl and amino termini domains on ox-LDL are in close approximation to each other and may recognize the same receptor on the macrophage.
The immunoreactivity of ox-LDL with Mabs B1B6 and B1B3, which are directed against the LDL recep- tor-binding domains on apo B-100, is 50% less than that of native LDL, suggesting considerable changes in the epitopes on ox-LDL in comparison with native LDL.
Determination of the relative purity of the ox-LDL preparation would be important, as contamination with native LDL particles could explain the results. Heparin binds to the positively charged amino acid residues of apo B-100, and at least four unique heparin-binding domains have been identified on apo B-100. 34 Native LDL but not ox-LDL possesses these heparin-binding characteristics. 35 These heparin-binding sites were employed to separate the oxidized particles (ub fractions) of ox-LDL from the nonoxidized retained particles. The eluted Upoprotein (ub fraction) was free of native LDL, and this lipoprotein (ub-ox-LDL) still contained the LDL receptor-binding domain.
Although several studies have demonstrated the lack of competition of unlabeled native LDL with 123 I-ox-LDL for cellular uptake and degradation by macrophages, 12 -1415 the competition of unlabeled ox-LDL with '"I-LDL, to the best of our knowledge, has not been analyzed previously. These competitions suggest that ox-LDL still contains epitopes that are also present in native LDL and that these epitopes are involved in the uptake of ox-LDL by macrophages. On the other hand, this study does not determine specific epitopes developed during oxidation, which may be involved in the uptake of ox-LDL by the scavenger receptor. The greater capacity of unlabeled ox-LDL in comparison with native LDL to compete with 125 I-ox-LDL for macrophage uptake may be related to the increased binding capacity of ox-LDL via multiple binding domains to the macrophage receptors in comparison with the low-affinity binding of native LDL to a single LDL receptor type on macrophages. Similarly, because of its low affinity for the LDL receptor on mouse macrophages, LDL does not compete effectively with 125 I-/3-VLDL or apo E-containing lipoproteins for receptor binding. 36 Because the LDL receptor could be fully downregulated after the uptake of ox-LDL by the scavenger receptor, the importance of the uptake of ox-LDL by the LDL receptor is not clear. It was reported recently 37 -38 that on SDS-PAGE, Western blot analysis, and enzyme-linked immunosorbent assay, ox-LDL revealed a positive interaction with Mab MB47 (which was shown to bind to the LDL receptor-binding domains). 37 -38 It should be taken into consideration that macrophages possess Fc receptors (which bind antibodies) and can also bind to the Mab that binds to ox-LDL. Thus, the macrophage may take up ox-LDL by phago-cytosis. 6 Because Mabs, as opposed to polyclonal antibodies, bind only to a single epitope, they may not be affected dramatically by the Fc receptor.
Interestingly, whereas ox-LDL was shown to bind to the macrophage LDL receptor and to the scavenger receptor, binding to the classical LDL receptor on human fibroblasts did not take place. The differential uptake of ox-LDL by the LDL receptor on macrophages as opposed to fibroblasts probably lies in the ubiquitous nature of the LDL receptor itself. LDL binds to MPMs with a 10-fold lower affinity than it does to cultured human fibroblasts. 36 Koo et al 36 reported recently that the LDL receptor on MPMs differs from the same receptors on HMDMs and fibroblasts with regard to its molecular size, binding affinity to LDL, and relative insensitivity to downregulation. Using specific antibodies against the rat liver LDL receptor, Ellsworth et al 39 have shown that MPMs, J774 macrophages, and a mouse fibroblast cell line (3T3) all possess LDL receptors with a molecular weight about 5,000 d less than that of the rat liver LDL receptor. Hoeg et al 40 compared the properties of the LDL receptor in human liver cells to that in human skin fibroblasts and found striking differences relating to the number and affinity of the receptors expressed by these two tissues. The fibroblast membrane had nearly 10-fold more receptors than the hepatic membrane, and the binding affinity was increased nearly fourfold. 40 Both MPMs and HMDMs express mainly the scavenger receptor (and to a lesser extent, the LDL receptor) and as a consequence may be less than optimal for the study of the uptake of ox-LDL through the LDL receptor. The J774A.1 macrophagelike cell line, however, exhibits a large number of LDL receptors, and thus, these macrophages are more suitable cells to study ox-LDL uptake via the LDL receptor. Both HMDMs and MPMs, when incubated with lipoprotein-deficient serum, upregulate the LDL-binding sites. The results with the upregulated cells were similar to those obtained with the cells that were not upregulated.
Ox-LDL was shown to bind to the macrophage ac-LDL receptor 10 as well as to another receptor that is unique to ox-LDL. 1415 The latter may be related to our finding of a binding domain on the ox-LDL apo B-100 amino terminus (related to Mab C14), which did not react with the ac-LDL receptor. Sparrow et al 14 suggested that a single receptor could have multiple binding sites, with several being available for ox-LDL. It is also possible that macrophages possess a collection of scavenger receptors with a similar basic structure and variable binding sites.
Recently, it was shown that one class of scavenger receptor recognizes ac-LDL, ox-LDL, and acidic phospholipids, whereas another type of scavenger receptor recognizes both acidic phospholipids and ox-LDL but not ac-LDL. 41 Ox-LDL possesses multiple binding domains, and the domains on the amino residue may express similar but not identical epitopes with ac-LDL. Ox-LDL reacts with Mab C14, located on the amino terminus of apo B-100, but not with Mab D3D5, which is located close to Mab C14. Ac-LDL reacts with Mab D3D5 but not with Mab C14. Two types of macrophage scavenger receptors that recognize ac-LDL have recently been elucidated, 42 -43 but it is not clear whether they also bind ox-LDL. Macrophage uptake of LDL is dependent on the type of lipoprotein modification, such as triglyceride, cholesteryl ester, and phospholipid hydrolysis or oxidation of the LDL fatty acids or cholesterol moieties.
4 -6 -44 - 46 The existence of multiple macrophage-binding sites on ox-LDL, if operable in vivo, can affect the rates of cellular uptake and processing of lipoproteins during atherogenesis.
